Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.
Microglia as a critical player in both developmental and late-life CNS pathologies.
Habitual Functional Electrical Stimulation Therapy Improves Gait Kinematics and Walking Performance, but Not Patient-Reported Functional Outcomes, of People with Multiple Sclerosis who Present with Foot-Drop.
Double Inversion Recovery Sequence of the Cervical Spinal Cord in Multiple Sclerosis and Related Inflammatory Diseases.
Statins and Neuroprotection: Basic Pharmacology Needed.
Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.
Angiotensin IV is Induced in Experimental Autoimmune Encephalomyelitis but Fails to Influence the Disease.
The story of neuromyelitis optica continues to be written.
Rotating-polarization CARS microscopy: combining chemical and molecular orientation sensitivity.
Circulating CCR7+ICOS+ Memory T Follicular Helper Cells in Patients with Multiple Sclerosis.
Prior regular exercise improves clinical outcome and reduces demyelination and axonal injury in experimental autoimmune encephalomyelitis.
A Novel Bmal1 Mutant Mouse Reveals Essential Roles of the C-Terminal Domain on Circadian Rhythms.
Anodal transcranial direct current stimulation of motor cortex does not ameliorate spasticity in multiple sclerosis.
Blind analysis: Hide results to seek the truth.
New methods for analysis of oxysterols and related compounds by LC-MS.
Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS.
Small-molecule Klotho enhancers as novel treatment of neurodegeneration.
Diffusivity signatures characterize trigeminal neuralgia associated with multiple sclerosis.
Interictal interleukin-17A levels are elevated and correlate with seizure severity of epilepsy patients.
[Local reactions to disease-modifying drugs: pathogenesis and relationship to clinical effectiveness.]
Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.
Tamoxifen administration immediately or 24 hours after spinal cord injury improves locomotor recovery and reduces secondary damage in female rats.
Identification of Dominant Human Aquaporin 4 T-Cell Epitopes: Observations in Neuromyelitis Optica With Implications for Other Autoimmune DisordershAQP4 T-Cell Epitopes.
Protein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders.
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course.
Pages
« first
‹ previous
…
397
398
399
400
401
402
403
404
405
…
next ›
last »